Skip to main content
Skip to footer
Home
Home
About
Overview
Management Team
Board of Directors
Medical & Scientific Advisors
Pipeline
Overview
NP-120 (Ifenprodil)
NP-251 (Repirinast)
AP-188 (DMT)
Companies
Algernon NeuroScience
News & Media
News Releases
IR Calendar
Presentations
Videos/Articles
Investors
Overview
News & Events
Company Info
Financial Info
Stock Data
SEDAR
Governance
Contact
Presentations
Investors
Investors
Overview
News & Events
Overview
News Releases
IR Calendar
Email Alerts
Company Info
Overview
Management Team
Presentations
Contacts
FAQ
Financial Info
Overview
Financial Results
Annual General Meeting
Analysts
Stock Data
CSE:AGN
OTCQB:AGNPF
XFRA:AGW0
SEDAR
Governance
Overview
Board of Directors
Board Committees
Governance Documents
Aug 25, 2023
Corporate Fact Sheet August 2023
Aug 24, 2023
Algernon Presentation Q3 2023
Mar 15, 2023
Algernon Presentation Q1 2023
rss_feed
RSS
Facebook
Twitter
LinkedIn
Email Alerts
Email Alerts
Contacts
RSS News Feed
